CCL Industries Inc.
CCDBF
$50.00
$1.172.40%
| Weiss Ratings | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B+ | |||
| Rating Factors | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.82 | |||
| Price History | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.64% | |||
| 30-Day Total Return | 1.13% | |||
| 60-Day Total Return | -4.06% | |||
| 90-Day Total Return | -14.40% | |||
| Year to Date Total Return | -2.45% | |||
| 1-Year Total Return | -3.45% | |||
| 2-Year Total Return | 14.15% | |||
| 3-Year Total Return | 17.88% | |||
| 5-Year Total Return | 89.03% | |||
| 52-Week High % Change | -18.39% | |||
| 52-Week Low % Change | 7.90% | |||
| Price | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $61.27 | |||
| 52-Week Low Price | $46.34 | |||
| 52-Week Low Price (Date) | Apr 05, 2024 | |||
| 52-Week High Price (Date) | Sep 26, 2024 | |||
| Valuation | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 8.79B | |||
| Enterprise Value | 9.92B | |||
| Price/Earnings (TTM) | 14.59 | |||
| Earnings Per Share (TTM) | 3.43 | |||
| Earnings Per Share Growth | 55.69% | |||
| Price/Earnings To Growth | 0.26 | |||
| Price/Sales (TTM) | 1.68 | |||
| Price/Book (Q) | 2.41 | |||
| Enterprise Value/Revenue (TTM) | 1.88 | |||
| Price | $50.00 | |||
| Enterprise Value/EBITDA (TTM) | 9.50 | |||
| Enterprise Value/EBIT | 12.92 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 178.02M | |||
| Dividend Yield | 1.69% | |||
| Div. Per Share (Most Recent) | $0.20 | |||
| Dividend Per Share (TTM) | $0.84 | |||
| Payout Ratio (TTM) | 24.47% | |||
| Dividend Per Share (Most Recent) | $0.20 | |||
| Company Info | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 756 8500 | |||
| Address | 111 Gordon Baker Road Toronto, ON M2H 3R1 | |||
| Website | www.cclind.com | |||
| Country | Canada | |||
| Year Founded | 1951 | |||
| Profitability | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 14.51% | |||
| Profit Margin | 11.64% | |||
| Management Effectiveness | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.05% | |||
| Return on Equity | 17.17% | |||
| Income Statement | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 5.29B | |||
| Total Revenue (TTM) | 5.29B | |||
| Revenue Per Share | $29.71 | |||
| Gross Profit (TTM) | 1.56B | |||
| EBITDA (TTM) | 1.04B | |||
| EBIT (TTM) | 767.49M | |||
| Net Income (TTM) | 615.74M | |||
| Net Income Avl. to Common (TTM) | 615.74M | |||
| Total Revenue Growth (Q YOY) | 5.96% | |||
| Earnings Growth (Q YOY) | 350.38% | |||
| EPS Diluted (TTM) | 3.43 | |||
| EPS Diluted Growth (Q YOY) | 364.88% | |||
| Balance Sheet | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 575.95M | |||
| Cash Per Share (Q) | $3.24 | |||
| Total Current Assets (Q) | 2.11B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 3.67B | |||
| Current Ratio (Q) | 2.011 | |||
| Book Value Per Share (Q) | $20.76 | |||
| Total Assets (Q) | 6.85B | |||
| Total Current Liabilities (Q) | 1.05B | |||
| Total Debt (Q) | 1.70B | |||
| Total Liabilities (Q) | 3.18B | |||
| Total Common Equity (Q) | 3.67B | |||
| Cash Flow | CCDBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -440.09M | |||
| Cash from Financing (TTM) | -307.32M | |||
| Net Change in Cash (TTM) | 38.63M | |||
| Levered Free Cash Flow (TTM) | 291.00M | |||
| Cash from Operations (TTM) | 775.07M | |||
